tiprankstipranks
Medipal Holdings Corporation (JP:7459)
TSE/TYO:7459

Medipal Holdings (7459) Stock Price & Analysis

0 Followers

7459 Stock Chart & Stats

Day’s Range¥0 - ¥0
52-Week Range¥2,143.04 - ¥2,618.56
Previous Close¥2,448
Volume560.30K
Average Volume (3M)519.11K
Market Cap
¥457.11B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)12.5
Beta0.72
Jul 31, 2024
Dividend Yield2.68%
Share Statistics
EPS (TTM)196.00
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume519,106
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
¥2,789.65
Price Target Upside13.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1

Options Prices

Currently, No data available
---

Ownership Overview

0.00%3.07%5.26%91.66%
0.00%
Insiders
5.26% Other Institutional Investors
91.66% Public Companies and
Individual Investors

7459 FAQ

What was Medipal Holdings Corporation’s price range in the past 12 months?
Medipal Holdings Corporation lowest stock price was ¥2143.04 and its highest was ¥2618.56 in the past 12 months.
    What is Medipal Holdings Corporation’s market cap?
    Currently, no data Available
    When is Medipal Holdings Corporation’s upcoming earnings report date?
    Medipal Holdings Corporation’s upcoming earnings report date is Jul 31, 2024 which is in 29 days.
      How were Medipal Holdings Corporation’s earnings last quarter?
      Medipal Holdings Corporation released its earnings results on May 14, 2024. The company reported ¥62.795 earnings per share for the quarter, beating the consensus estimate of ¥41.18 by ¥21.615.
        Is Medipal Holdings Corporation overvalued?
        According to Wall Street analysts Medipal Holdings Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Medipal Holdings Corporation pay dividends?
          Medipal Holdings Corporation pays a Annually dividend of ¥30 which represents an annual dividend yield of 2.68%. See more information on Medipal Holdings Corporation dividends here
            What is Medipal Holdings Corporation’s EPS estimate?
            Medipal Holdings Corporation’s EPS estimate is ¥56.56.
              How many shares outstanding does Medipal Holdings Corporation have?
              Medipal Holdings Corporation has 221,291,340 shares outstanding.
                What happened to Medipal Holdings Corporation’s price movement after its last earnings report?
                Medipal Holdings Corporation reported an EPS of ¥62.795 in its last earnings report, beating expectations of ¥41.18. Following the earnings report the stock price went down -1.143%.
                  Which hedge fund is a major shareholder of Medipal Holdings Corporation?
                  Currently, no hedge funds are holding shares in JP:7459
                  ---

                  Medipal Holdings Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Company Description

                  Medipal Holdings Corporation

                  Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and OTC Pharmaceutical Wholesale Business segment deals with wholesale business for drugstores, home centers, convenience stores, and supermarkets. The Animal Health Products Wholesale Business segment handles wholesale business for animal hospitals, farms, agricultural cooperatives, and processed food manufacturers. The company was founded on October 8, 1898 and is headquartered in Tokyo, Japan.
                  ---

                  7459 Stock 12 Month Forecast

                  Average Price Target

                  ¥2,789.65
                  ▲(13.96% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2230":"¥2,230","2791":"¥2,791","2370.25":"¥2,370.3","2510.5":"¥2,510.5","2650.75":"¥2,650.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2790.03138791468,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">¥2.79K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2789.65449464,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">¥2.79K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2790.03138791468,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">¥2.79K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2230,2370.25,2510.5,2650.75,2791],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Dec<br/>2023","9":"Mar<br/>2024","12":"Jun<br/>2024","25":"Jun<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2307,2344.1562606088214,2381.3125212176433,2418.4687818264647,2455.625042435286,2492.781303044108,2529.9375636529294,2567.093824261751,2604.250084870572,2641.406345479394,2678.5626060882155,2715.718866697037,2752.8751273058588,{"y":2790.03138791468,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2307,2344.1272688184617,2381.254537636923,2418.381806455385,2455.509075273846,2492.636344092308,2529.763612910769,2566.890881729231,2604.018150547692,2641.145419366154,2678.272688184615,2715.399957003077,2752.527225821538,{"y":2789.65449464,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2307,2344.1562606088214,2381.3125212176433,2418.4687818264647,2455.625042435286,2492.781303044108,2529.9375636529294,2567.093824261751,2604.250084870572,2641.406345479394,2678.5626060882155,2715.718866697037,2752.8751273058588,{"y":2790.03138791468,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2294.104,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2403.881,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2488.287,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2473.798,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2575.494,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2571.052,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2358.772,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2290.645,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2321.746,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2231.898,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2340,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2483,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2307,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Medipal Holdings
                  Galera Therapeutics
                  Crinetics Pharmaceuticals
                  Humana
                  Walgreens Boots Alliance

                  Best Analysts Covering 7459

                  1 Year
                  1 Year Success Rate
                  2/4 ratings generated profit
                  50%
                  1 Year Average Return
                  -2.30%
                  reiterated a buy rating 30 days ago
                  Copying Miyabi Yamakita's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -2.30% per trade.
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis